QNB

Consumer Goods and Services

Baladna (BLDN)

Baladna (BLDN) - Strong GPM Print Lifts Profit, Dividend Outlook Weighs On Valuation; Lowering TP-20-05-2025
BLDN - Earnings Momentum Continues Despite 3Q2024 Miss; FY2024 Estimates Trimmed; Stay Outperform-28-10-24
BLDN - 2Q2024 Earnings Beat on Higher GP Margin and Lower Selling General and Admin Expenses; Maintain OUTPERFORM-24-07-2024
BLDN - In-line 1Q2024 on Strong Product Volumes and Margin Recovery; Maintain Outperform 25-04-2024
BLDN - 4Q2023 NP Beats Estimate as Board Pays out More Than 100 Percent; Upgrade to Outperform-26-02-2024
BLDN - Slight 3Q2023 Bottom-Line Beat On Lower Finance Costs; Maintain Accumulate - 30-10-2023
Baladna (BLDN) Alert - Flat 2Q2023 Bottom-Line As Finance Costs Double; Maintain Accumulate-07-08-2023
Baladna (BLDN) Initiation Report - Volume Headway and PE-like Optionality Implies Compelling Upside; Initiate with Accumulate-31-07-2023
BLDN Alert Memorandum to Produce Diary Products in Malaysia is a Positive; Accumulate-17-08-2021
BLDN Alert - Miss Due to Lower - than - Expected Margins; Maintain TP, Accumulate-12-08-2021
BLDN Alert - In-Line Results with Lower GA; Maintain TP Accumulate-28-04-2021
BLDN Alert - In-Line Operational Results Better-than-Expected DPS; Accumulate-18-03-2021
BLDN Alert - Weaker-than-Expected 3Q with Lower Revenue; Maintain TP Accumulate-27-10-2020
BLDN - Raising Our Target Price to QR1.94 Changing our Recommendation to Accumulate-16-09-2020
BLDN - New Products and Exports to Drive Growth; Initiate with Outperform-31-05-2020

Medicare Group (MCGS)

MCGS - 1Q2025 Earnings Miss on Lower Revenue and Margin Shrinkage; Stay Accumulate-22-04-25
MCGS - Upping Estimates Post A Solid Normalized 4Q & FY2024; Maintain Accumulate-04-03-25
MCGS - Upbeat 3Q2024 Earnings; Decision To Close Al Wakra Clinic Vindicated; Maintain Accumulate-24-10-24
MCGS - Normalized 2Q2024 Net Profit Beat on Higher Top-Line and Margin-Expansion; Upgrade To Accumulate-22-07-2024
MCGS - Court Ruling Implies Potential Positive Impact of QR0.25 Per Share; Maintain Market Perform-21-05-2024
MCGS - 1Q2024 Beat on Higher Top Line and Commendable Margin Recovery; Maintain Market Perform-28-04-2024
MCGS - 4Q2023 Misses Estimate As Staff Costs Bulge Despite In-Line Revenue; Lowering Price Target-21-02-2024
Medicare (MCGS) - Curtailing Full-Year Estimates But Stock Remains Cheaper Than International Peers; Maintain Market Perform-14-11-2023
MCGS - 3Q2023 Miss As Revenue Disappoints and Margins Shrink; Reducing Price Target-24-10-2023
MCGS Alert – 2Q2023 Better Than Feared on Lower Medication and Surgical Costs; Maintain Market Perform-19-07-2023
Medicare (MCGS) -Trimming Estimates and Price Target But Defensive Attributes Support Our Market Perform Rating-25-05-23
MCGS 1Q2023 Alert – Net Profit Miss on Higher COGS as Revenue Tops Estimate; Reiterate Market Perform-19-04-2023
MCGS Alert – 4Q2022 Earnings Miss As World Cup Adversely Affects Activity; Stay Market Perform
Medicare (MCGS) Initiation Report - Defensive Attributes Compensate For Muted Growth; Initiate Coverage With Market Perform-24-11-2022
MCGS - 2H2021 Recovery Expected on Demand Pickup Amid Lower Restrictions; Retain MP-05-08-2021
MCGS Alert - 2Q2021 Miss Due to Lower Margins & Higher G&A; Retain TP & MP-25-07-2021
MCGS - Tweaking our post-2021 Estimates Target Price; Retain Market Perform-03-05-2021
MCGS Alert - 1Q2021 Profit Dips Below Forecast Due to Lower Revenue; Retain TP & MP-22-04-2021
MCGS Alert Private Hospitals to Halt Non-Emergency Care Given Covid-19 Precautions; Market Perform-01-04-2021
MCGS Alert - Better than Expected 4Q2020_Maintain TP_MP-24-02-2021
MCGS Alert - Better than Expected 3Q2020_Maintain TP_MP-21-10-2020
MCGS Alert - MCGS Discloses a Court Ruling to Receive QR130.7mn-01-10-2020
MCGS - Lowering Estimates Maintain MP and Target Price at QR8.04-06-09-2020
MCGS Alert - 2Q2020 Miss Due to Lower Revenues Higher GA_Maintain TP MP-29-07-2020
MCGS - In-Line 1Q2020 Excluding Provisions; We Maintain Our Estimates Target Price-29-04-2020
MCGS - Waiting for Seha; Revising Estimates Target Price Down; Maintain MP-10-02-2020
MCGS - Alert 4Q2019 EPS Beat Due to Non-Operating Items Maintain TP Market Perform-05-02-2020
MCGS - 3Q2019 Results_EPS Beat With Lower G&A_Market Perform-10-10-2019
MCGS - Healthy Outlook but Mostly Priced In; Initiating Coverage with MP-27-08-2019

Was this information helpful?